CCN2/CTGF has been identified as an independent prognostic indicator of both tumor recurrence and overall survival for intrahepatic CCA patients regardless of tumor location, tumor grade, or vascular and perineural invasion [30]. The gene discussed is CCN2; the disease is cholangiocarcinoma.